Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLX-7486 plus gemcitabine in advanced cancer and pancreatic ductal adenocarcinoma
ISRCTN10978180Phase 2Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jul 2019
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of opn-7486 and gemcitabine in advanced nonhematological malignancy and pancreatic adenocarcinoma (PDAC), sponsored by NHS Greater Glasgow and Clyde. Started Jul 2019; status: terminated.
02
Drugs
opn-7486gemcitabine
03
Conditions
advanced nonhematological malignancypancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on ISRCTN10978180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10978180.